Cargando…

Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report

Parkinson's disease (PD) is a neurodegenerative disease that involves the loss of dopaminergic neurons in the substantia nigra pars compacta of the basal ganglia. Clinically, patient presentation involves a combination of motor and non-motor symptoms characterized by progressive worsening over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vij, Ridhima, Prossin, Alan, Tripathy, Mallika, Kim, Hosu, Park, Hyeonggeun, Cheng, Thanh, Lotfi, Djamchid, Chang, Donna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569690/ https://www.ncbi.nlm.nih.gov/pubmed/37840944 http://dx.doi.org/10.3389/fneur.2023.1257080

Ejemplares similares

Frequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case report
por: Vij, Ridhima, et al.
Publicado: (2022)

Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program
por: Vij, Ridhima, et al.
Publicado: (2023)

Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial
por: Vij, Ridhima, et al.
Publicado: (2022)

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2018)

Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study
por: DuPont, Herbert L., et al.
Publicado: (2023)

Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
por: Wang, Zekun, et al.
Publicado: (2023)

Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)
por: Rice, Claire M, et al.
Publicado: (2015)

Safety of Low Dose Intravenous Cangrelor in Acute Ischemic Stroke: A Case Series
por: Salahuddin, Hisham, et al.
Publicado: (2021)

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
por: Zheng, Wei, et al.
Publicado: (2023)

Case Report: Repeated Low-Dose Rituximab Treatment Is Effective in Relapsing Neuro Behçet's Disease
por: Zhao, Chao, et al.
Publicado: (2021)

Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
por: Li, Bing-Hu, et al.
Publicado: (2022)

Analyses on safety and efficacy of non-standard dose of r-tPA in intravenous thrombolysis-treated AIS patients
por: Yuan, Jiawen, et al.
Publicado: (2022)

Low-Dose vs. Standard-Dose Intravenous Alteplase in Bridging Therapy Among Patients With Acute Ischemic Stroke: Experience From a Stroke Center in Vietnam
por: Mai, Duy Ton, et al.
Publicado: (2021)

Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication
por: Straka, Igor, et al.
Publicado: (2019)

Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease
por: Linetsky, Eduard, et al.
Publicado: (2022)

SLC6A4 Repeat and Single-Nucleotide Polymorphisms Are Associated With Depression and Rest Tremor in Parkinson's Disease: An Exploratory Study
por: Wang, Jian-Yong, et al.
Publicado: (2019)

Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
por: du Plessis, Stefan, et al.
Publicado: (2020)

Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review
por: Liu, Shu-fen, et al.
Publicado: (2022)

Long-Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cell Injections in Patients With Progressive Forms of Multiple Sclerosis
por: Petrou, Panayiota, et al.
Publicado: (2021)

Slurring of Speech and Lip Paresthesia: Symptoms of Levodopa End of Dose Wearing Off in Parkinson's Disease
por: Nasir, Usama, et al.
Publicado: (2018)

Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease
por: Fan, Qian-Ya, et al.
Publicado: (2022)

Carbidopa/levodopa dose elevation and safety concerns in Parkinson's patients: a cross-sectional and cohort design
por: Brodell, David W, et al.
Publicado: (2012)

Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan
por: Chang, Chun-Wei, et al.
Publicado: (2019)

Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory
por: Černík, David, et al.
Publicado: (2021)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
por: Zhang, Yu, et al.
Publicado: (2023)

Intravenous Thrombolysis in Posterior Circulation Stroke
por: Dorňák, Tomáš, et al.
Publicado: (2019)

Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

The Use of Autologous Blood Patch in Ullrich Muscular Dystrophy and Recurrent Pneumothorax
por: Navas Nazario, Aledie, et al.
Publicado: (2022)

Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol
por: Pfeifer, Kristina J., et al.
Publicado: (2021)

Bridging intravenous thrombolysis in patients with atrial fibrillation
por: Mujanovic, Adnan, et al.
Publicado: (2022)

Safety and Efficacy of Low-Dose Tirofiban Combined With Intravenous Thrombolysis and Mechanical Thrombectomy in Acute Ischemic Stroke: A Matched-Control Analysis From a Nationwide Registry
por: Ma, Gaoting, et al.
Publicado: (2021)

Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study
por: Townsend, Robert, et al.
Publicado: (2015)

Severe Constipation in Parkinson's Disease and in Parkinsonisms: Prevalence and Affecting Factors
por: Frazzitta, Giuseppe, et al.
Publicado: (2019)

Modern Brainstem MRI Techniques for the Diagnosis of Parkinson's Disease and Parkinsonisms
por: Arribarat, Germain, et al.
Publicado: (2020)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Repeat-dose toxicity study of human umbilical cord mesenchymal stem cells in cynomolgus monkeys by intravenous and subcutaneous injection
por: Pan, Wei, et al.
Publicado: (2023)

Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018)

Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat
por: Sugiyama, Yuichiro, et al.
Publicado: (2018)

Medical Case Report on Repeat Treatment of Restless Legs Syndrome with Intravenous Infusion of Iron
por: Condon, Katherine, et al.
Publicado: (2021)

Chronic Neurophysiological Effects of Repeated Head Trauma in Retired Australian Male Sport Athletes
por: Pearce, Alan J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5279odcv3jns6k9i3hknk9sf4d